QT
AMRX icon

Quantbot Technologies’s Amneal Pharmaceuticals AMRX Stock Holding History

Quantbot Technologies’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.45M Sell
141,629
-35,150
-20% -$482K 0.1% 301
2026
Q1 		$2.2M Buy
176,779
+143,649
+434% +$1.93M 0.09% 350
2025
Q4 		$417K Sell
33,130
-118,390
-78% -$1.35M 0.01% 1001
2025
Q3 		$1.52M Sell
151,520
-116,756
-44% -$1.05M 0.04% 636
2025
Q2 		$2.17M Sell
268,276
-529
-0.2% -$3.99K 0.06% 505
2025
Q1 		$2.25M Buy
268,805
+149,272
+125% +$1.25M 0.07% 401
2024
Q4 		$947K Buy
119,533
+8,352
+8% +$70.1K 0.03% 646
2024
Q3 		$925K Buy
111,181
+81,519
+275% +$637K 0.04% 658
2024
Q2 		$188K Buy
+29,662
New +$188K 0.01% 986
2023
Q3 		– Sell
-1
Closed -$3 – 1514
2023
Q2 		$3 Sell
1
-11,156
-100% -$23.8K ﹤0.01% 1516
2023
Q1 		$15.5K Sell
11,157
-29,198
-72% -$58.1K ﹤0.01% 1376
2022
Q4 		$80.3K Sell
40,355
-249
-0.6% -$558 0.01% 1199
2022
Q3 		$82K Buy
40,604
+35,504
+696% +$99.5K 0.01% 1151
2022
Q2 		$16K Buy
+5,100
New +$18.5K ﹤0.01% 1472
2020
Q1 		– Sell
-57,033
Closed -$274K – 881
2019
Q4 		$274K Buy
57,033
+43,274
+315% +$150K 0.03% 575
2019
Q3 		$39K Sell
13,759
-20,112
-59% -$70.2K ﹤0.01% 1028
2019
Q2 		$242K Buy
+33,871
New +$346K 0.02% 543
2019
Q1 		– Sell
-597
Closed -$8K – 986
2018
Q4 		$8K Buy
+597
New +$10.8K ﹤0.01% 944

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Quantbot Technologies's AMRX Position: Q2 2026 in Review

Quantbot Technologies reduced its Amneal Pharmaceuticals (AMRX) stake by 20% in Q2 2026, selling an estimated $482K and leaving 141,629 shares worth $2.45M. The position accounts for 0.1% of the portfolio, ranked #301.

Quantbot Technologies first reported a position in AMRX in Q4 2018 and has held it in 18 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Quantbot Technologies held 141,629 shares of Amneal Pharmaceuticals worth $2.45M as of Q2 2026.
  • Quantbot Technologies sold 35,150 Amneal Pharmaceuticals shares in Q2 2026, an estimated $482K.
  • Amneal Pharmaceuticals made up 0.1% of Quantbot Technologies's portfolio in Q2 2026, its #301 holding.
  • Quantbot Technologies first reported a position in Amneal Pharmaceuticals in Q4 2018 and has held it in 18 quarters since.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.